Financial Data and Key Metrics Changes - The company reported non-GAAP gross billings of $25.8 billion for Q1, a 24% increase year-over-year, or 20% in constant currency, exceeding guidance [14] - Non-GAAP operating income was $590 million, up 48% year-over-year, and non-GAAP earnings per share reached $4.73, a 69% increase year-over-year [14] - GAAP operating income was $489 million, a 61% increase year-over-year, with GAAP earnings per share at $4.04, up 104% year-over-year [15] Business Line Data and Key Metrics Changes - Distribution generated non-GAAP gross billings of $22 billion, a 17% increase year-over-year, driven by strength across product categories and geographies [15] - Hyve generated non-GAAP gross billings of $3.8 billion, a 95% increase year-over-year, with manufacturing and assembly growing in the mid-70% range [16][17] - Distribution's non-GAAP operating income was $431 million, a 42% increase year-over-year, while Hyve's non-GAAP operating income was $159 million, a 66% increase year-over-year [16][17] Market Data and Key Metrics Changes - The company noted strong performance in infrastructure software and security, with notable strength in PCs as partners navigate inflationary costs [7] - The European distribution market grew mid-single-digit in Q1, with the company achieving double-digit growth, significantly outpacing the market [96] Company Strategy and Development Direction - The company is focusing on two primary business segments: Distribution and Hyve, each with distinct value propositions and growth drivers [6] - Strategic pillars include omnichannel engagement, specialized go-to-market strategies, best-in-class enablement, and expanding brand visibility [8] - Hyve is evolving towards complete system-level solutions across traditional compute, accelerated compute, networking, and storage offerings [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in long-term value creation opportunities across both Distribution and Hyve, with expanding addressable markets [13] - The company remains cautiously optimistic for the second half of the fiscal year, acknowledging strong demand but potential challenges from the macro environment [35] Other Important Information - Free cash flow usage for the quarter was approximately $929 million, with $1.2 billion generated over the trailing twelve months [18] - The company returned $723 million to shareholders, demonstrating a disciplined approach to capital allocation [18] - A cash dividend of $0.48 per common share was approved, payable on April 29, 2026 [20] Q&A Session Summary Question: Can you elaborate on the growth in Hyve Solutions? - Management indicated that growth was primarily from two main customers, with diversification expected to ramp up towards the end of fiscal year 2026 [24] Question: What is the outlook for PC demand? - Management remains optimistic about PC demand, particularly in the B2B segment, despite potential reductions in unit sales due to price increases [28] Question: How are you managing inventory and cash flow? - The company has improved cash conversion days and is managing inventory to ensure adequate supply amidst potential shortages [26][19] Question: What are the expectations for Hyve's growth and margins? - Hyve is expected to continue growing faster than Distribution, with current margins stable but potential initial pressure as new programs ramp up [46][91] Question: How is the geopolitical environment affecting European distribution? - The European market is growing mid-single-digit, with the company achieving double-digit growth, indicating a positive market sentiment [96]

Core Viewpoint - DXP Enterprises, Inc. reported strong financial results for the fourth quarter and fiscal year 2025, highlighting significant revenue growth, increased net income, and successful acquisitions, positioning the company for continued success in 2026 [1]. Financial Highlights - Fiscal 2025 sales reached $2.0 billion, an increase of 11.9% from fiscal 2024 [1]. - Net income for fiscal 2025 was $88.7 million, up 25.8% from $70.5 million in fiscal 2024 [1]. - Adjusted EBITDA for fiscal 2025 was $225.3 million, representing a 17.8% increase from $191.3 million in 2024 [1]. - Diluted earnings per share for fiscal 2025 were $5.37, compared to $4.22 in 2024 [1]. Fourth Quarter Performance - Sales for the fourth quarter of 2025 were $527.4 million, a 12.0% increase from $470.9 million in the fourth quarter of 2024 [1]. - Net income for the fourth quarter was $22.8 million, up 6.9% from $21.4 million in the same quarter of 2024 [1]. - Adjusted EBITDA for the fourth quarter was $59.0 million, compared to $50.3 million in the fourth quarter of 2024 [1]. Business Segment Performance - Supply Chain Services revenue for fiscal 2025 was $252.9 million, a decrease of 1.4% year-over-year [1]. - Innovative Pumping Solutions revenue increased by 26.4% to $390.3 million [1]. - Service Centers revenue grew by 11.0% to $1.4 billion [1]. Strategic Actions - The company completed six acquisitions during the fiscal year, enhancing its market position [1]. - DXP repurchased 0.2 million shares for $17.0 million in fiscal 2025 [1]. - The company refinanced its Senior Secured Term Loan B, raising an additional $205 million and reducing borrowing costs by 50 basis points [1]. Outlook - The company expressed confidence in its growth strategy and operational discipline, anticipating positive dynamics in end markets such as water & wastewater and energy in the second half of 2026 [1].

Core Insights - Celestica Inc. (NYSE:CLS) is highlighted as a significant player in the AI ecosystem, particularly due to its partnership with Broadcom, which positions it favorably in the market [2] - Jim Cramer emphasizes that the perception of AI demand as "zero sum" is misguided, suggesting that there is ample opportunity for multiple companies to thrive in this space [2] - Celestica's stock has seen a remarkable increase of approximately 270-280%, indicating strong market performance and investor interest [2] Company Overview - Celestica Inc. provides contract manufacturing, supply chain, and various services to businesses, making it a key player in the technology supply chain [2] - The company is recognized as a preferred partner for Broadcom, which enhances its credibility and potential for growth within the AI sector [2] Market Perspective - The discussion around Celestica reflects a broader trend in the market where multiple players can coexist and succeed, countering the notion that advancements by one company necessarily detract from others [2] - There is a belief that while Celestica shows promise, other AI stocks may offer higher returns with limited downside risk, indicating a competitive landscape in AI investments [2]

Core Insights - DXP Enterprises, Inc. has completed the acquisition of APSCO, LLC, enhancing its water and wastewater platform [1][3] - APSCO, founded in 1986, is a leading manufacturer's representative in the water and wastewater industry, servicing multiple states [2][4] - The acquisition was funded with cash from DXP's balance sheet, indicating a strategic investment in expanding its market presence [2][5] Financial Summary - APSCO reported sales of approximately $12.9 million and adjusted EBITDA of $1.5 million for the twelve months ending July 31, 2025 [4] - Adjusted EBITDA is defined as income before tax, plus interest, depreciation, amortization, and non-recurring items, minus go-forward selling costs [4] Strategic Implications - The acquisition is expected to enhance DXP's product and aftermarket service capabilities, contributing to the growth of its DXP Water platform [3][5] - DXP aims to continue its acquisition strategy in the water and wastewater sector, with plans for further acquisitions into 2026 [5]

Group 1 - Cardinal Health, Inc. (NYSE:CAH) is recognized as one of the 11 cheap quarterly dividend stocks to buy currently [1] - The company is a significant distributor of branded and generic drugs, medical supplies, and laboratory products, serving over 90% of hospitals in the US and operating in more than 30 countries [2] - Cardinal Health has a strong dividend history, having raised its payout for 39 consecutive years, with a payout ratio of about 25% of this year's expected earnings, indicating potential for further increases [3] Group 2 - The current quarterly dividend offered by Cardinal Health is $0.5107 per share, resulting in a dividend yield of 1.32% as of September 23 [4] - Analysts project an earnings growth of nearly 11% annually over the next three to five years, which could support continued dividend expansion [3]